Table 1 Clinical features of 289 patients with NB diagnosis
Mass screening | Standard | |||
|---|---|---|---|---|
Characteristics | Number (%) | Survival (%) | Numbers (%) | Survival (%) |
Total | 55 (100) | 98 | 234 (100) | 71.3 |
Gender | ||||
Female | 26 (47.3) | 114 (48.7) | ||
Male | 29 (52.7) | 120 (51.3) | ||
Age | ||||
Median (range) in months | 30 (0-151) | 25 (0-183) | ||
< 1 year | 52 (94.5) | 98 | 73 (31.2) | 91.7 |
1-5 years | 3 (5.5) | 100 | 121 (51.8) | 65.2 |
> 5 years | 40 (17) | 52.5 | ||
Clinical stage | ||||
1 | 16 (29.1) | 100 | 52 (22.2) | 94.2 |
2 | 15 (27.2) | 93 | 32 (13.7) | 100 |
3 | 9 (16.4) | 100 | 35 (15) | 85.7 |
4 | 6 (10.9) | 100 | 97 (41.4) | 42.2 |
4S | 9 (16.4) | 100 | 18 (7.7) | 83.3 |
MYCN oncogene | ||||
< 10 copies | 54 (98.2) | 100 | 160 (82.9) | 79.6 |
> 10 copies | 1 (1.8) | 0 | 33 (18.1) | 53.1 |